Skip to content
‹ Back to IndustriesSciences

How Freezing Temperatures Became the Hottest Trend in Wellness

The beauty industry is an economic gold mine and consumers are on a constant journey of exploration. One practice in particular, cryotherapy, has continued to defy conventional wisdom within the anti-aging and weight loss industry. The emerging method has both women and men pouring money into this cutting-edge wellness movement. What began as a pain…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Ally Shay · · Ally Shay ArticleCryoCryotherapyHealth
Share
How Freezing Temperatures Became the Hottest Trend in Wellness

Key takeaways

01

The beauty industry is an economic gold mine and consumers are on a constant journey of exploration.

02

One practice in particular, cryotherapy, has continued to defy conventional wisdom within the anti-aging and weight loss industry.

03

The emerging method has both women and men pouring money into this cutting-edge wellness movement.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The beauty industry is an economic gold mine and consumers are on a constant journey of exploration. One practice in particular, cryotherapy, has continued to defy conventional wisdom within the anti-aging and weight loss industry. The emerging method has both women and men pouring money into this cutting-edge wellness movement.

What began as a pain management tool and treatment for cancers, dementia and other illnesses, has transformed into an increasingly popular health craze.

The Science Behind the Craze

Cryotherapy is the process of subjecting the body to temperatures of up to -200 degrees Fahrenheit for around three minutes in a localized chamber. Physiologically, the change in temperature triggers a fight or flight response, forcing the body to enrich the organs with oxygen and increase circulation in an attempt to survive.

In 2015, the global cryotherapy market accounted for $2.5 billion and is projected to grow at a compound annual growth rate of 9.7% during a forecast period that continues to 2024, according to Grandview Research.

The cosmetic results of the process have been known to reduce cellulite, kick-start the metabolism, increase collagen production that reduces wrinkles and tighten pores. It has even been shown to release endorphins due to a Zen-like feeling that comes when the brain is forced into a heightened state, desperate for subsistence.

The extremes we go to for beauty, right?

Warming up to Change

While a lot of industries are hesitant to introduce change and risk breaking consumer routines, beauty and wellness is not one of them.

President and CEO of Shiseido Americas Marc Rey highlighted in an interview with Forbes that traditional makeup sales were down 1.3% in 2016, but independent brands were up 42.7%. This industry is a rare one in the sense that consumers are not only open to change, but often want to be the first to embrace it. Trends that begin as “hole in the wall” businesses like cryotherapy attract a fresh demographic and the growth of these types of corporations represent just how receptive consumers are to change.

While the more superficial benefits have yielded an incredible market, the medical-centric consumers back research adequate to warrant transforming oneself into a human icicle.

The chamber freezes abnormal tissue which can be attributed to killing certain cancers. The freezing conditions act as an ice bath taken to an extreme which helps aches, pains, muscle recovery and arthritis. Other medical benefits include migraine treatment, and the anti-inflammatory and oxidative stress process has even been known to help treat Alzheimer’s disease and Dementia.

Is the Freeze a Fad?

From a business standpoint, consumer behavior in response to a trend is not necessarily a telling factor of how the future of an industry will perform. However, consider this statement: no pain, no gain. We as consumers have translated this saying into our health, beauty and overall attitude about wellness. As technology and science continue to manifest new ways to achieve beauty, consumers have raised expectations on results.

In other words, if we were suddenly expected to fetch our water from a river and manually purify it, filling the Brita would not seem so arduous. Consumers are more and more willing to try new trends as the number of opportunities or services themselves increase.

While certain fads are important in how businesses adapt, they are not dependent on dynamic consumer behavior but rather on this overarching theme that combines millennials’ expectations with subjection to science experiments of their own volition. Cryotherapy is no exception.

Participating in trends allows consumers to feel like they are fully utilizing this science and technology. While Cryo might seem drastic compared to conventional methods of weight loss or anti-aging, this is the reality in how the beauty industry has evolved, and corporations have every right to capitalize on it in hopes of remaining relevant in a rapidly changing market.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

AS
Ally Shay
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

AS
Ally Shay

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512